One Connected Platform for Independent Pharmacies

Eli Lilly Just Sparked a GLP-1 Price War. And Compounders Should Pay Attention

When Eli Lilly slashed the price of Zepbound , it wasn’t an act of generosity. It was a calculated power move. A big one. This is Lilly making a statement in the fastest-growing drug category in the world and taking direct aim at Novo Nordisk and the thriving